RABIGEN MONO INJ 1 ML

Globally Recommended, Internationally Validated Potency: Rabigen Mono contains the inactivated VP12 rabies virus strain at a minimum potency of >1.0 IU per dose the international standard set by the WHO and OIE for protective rabies vaccines. This potency is independently validated through rigorous batch-release testing, ensuring that every vial delivered to your pet meets the same protective standard as vaccines used in government-led rabies elimination programmes worldwide.

High Virus-Neutralising Antibody (VNA) Titre Achievement: Rabigen Mono is clinically recognised for consistently achieving high VNA titres in vaccinated animals the gold-standard immunological benchmark for rabies protection. High VNA titres correlate directly with robust, durable protective immunity, reducing the risk of vaccine failure even under conditions of high viral challenge, and supporting successful titration results in international travel health certification requirements for pets.

Broad Species Applicability Dogs, Cats, and All Mammals: Unlike species-restricted anti-rabies products, Rabigen Mono's CDSCO import approval and clinical indication covers dogs, cats, cattle, horses, and in principle all mammals providing veterinary practitioners with a single trusted product across multiple species contexts, from urban companion animal clinics to farm animal and wildlife rescue settings.

Inactivated Vaccine Impossible to Cause Rabies: As a killed (inactivated) vaccine, Rabigen Mono contains no live virus capable of replication or disease causation. The vaccine can under no circumstances cause rabies in the vaccinated animal a safety assurance that distinguishes it categorically from any live or modified-live viral vaccine and makes it universally safe for use in all healthy animals regardless of immune status.

Adjuvanted for Superior Immune Response Duration: The aluminium hydroxide gel adjuvant system amplifies and extends the humoral immune response, ensuring that the antibody titres generated after vaccination are not only high at peak but are sustained at protective levels throughout the inter-booster interval reducing the risk of titre waning between scheduled vaccination appointments.

Individually Sealed Single-Dose Vial Presentation: Each 1ml vial contains a single, precisely measured dose for one animal, eliminating the risks of under-dosing, cross-contamination, or potency degradation associated with multi-dose vials improperly stored after opening ensuring every animal receives a full, sterile, potency-assured protective dose.

CDSCO-Approved Import, Virbac-Manufactured Quality Assurance: Rabigen Mono is manufactured by Virbac SA the world's sixth largest dedicated veterinary biopharmaceutical group under GMP conditions, and imported into India under official CDSCO import permit. Every batch meets international regulatory release criteria before reaching the Indian market.

How to Use:

Rabigen Mono must be administered by a licensed veterinarian. It must not be self-administered by pet owners. Administer by intramuscular (I/M) or subcutaneous (S/Q) injection at a dose of 1ml per animal, regardless of species, age, breed, or body weight.

Storage Advice:

Store Rabigen Mono vials in a refrigerator between 2°C and 8°C at all times. Do not freeze freezing will irreversibly destroy vaccine potency and the vial must be discarded if freezing occurs. Protect from direct light. Once removed from refrigerated storage, the vaccine should be used promptly and administered without delay. Once the vial is opened, the entire contents must be used immediately do not store a partially used or opened vial for later use. Keep out of reach of children. Do not use after the expiry date printed on the vial label and outer box. Transport must be maintained within the cold chain vaccines that have been outside the 2°C to 8°C range for any significant period should be discarded and not administered.

About Virbac Animal Health India Pvt. Ltd:

Virbac an acronym of virology and bacteriology was founded in 1968 in Nice, France, by Pierre-Richard Dick, a veterinary surgeon trained at the Pasteur Institute, who recognised that the animal health needs of companion animals were being systemically underserved by a pharmaceutical industry focused overwhelmingly on livestock and human medicine. From that founding conviction, Virbac grew into the world's sixth largest dedicated veterinary biopharmaceutical group the only major veterinary company exclusively focused on animal health from its very inception, without the competing priorities of human pharmaceutical divisions. Virbac's vaccine heritage is remarkable: the company developed the first homologous vaccine against canine parvovirus in 1982, the first genetically engineered vaccine against feline leukaemia in 1988, and pioneered the oral anti-rabies vaccine for foxes milestones that have permanently shaped the trajectory of companion animal preventive medicine. Today, Virbac operates in over 100 countries with 35 sales subsidiaries, production facilities across 10 countries, and 8 research and development centres, covering the majority of pathologies across companion animals, livestock, poultry, equine, and aquaculture species. In India, Virbac Animal Health India Pvt. Ltd. a wholly owned subsidiary of Virbac SA, headquartered in Mumbai strengthened its position as the number one animal health company in the country through the strategic acquisition of Agrivet Farm Care, the animal health division of GlaxoSmithKline.Virbac India serves veterinarians and animal owners across livestock, poultry, equine, companion animal, and aquaculture segments through a national distribution network of 25 carrying and forwarding agents. Virbac's unwavering commitment to the science of animal health, its legacy of vaccine innovation, and its focus on zoonotic disease control including its frontline role in global rabies elimination efforts align deeply with Animeal's mission to protect and advance the health of every animal in India. Discover Virbac today.

Disclaimer:
Please note that Virbac Rabigen Mono is a veterinary prescription biological product an inactivated rabies vaccine and must be prescribed, handled, and administered exclusively by a licensed veterinarian. This vaccine must not be self-administered by pet owners. Vaccines are biological products that require strict cold chain maintenance between 2°C and 8°C from manufacture to point of administration any break in the cold chain may compromise vaccine potency and protective efficacy without visible change to the vial's appearance. A vaccine that has been frozen, exposed to temperatures above 8°C for extended periods, or stored incorrectly must not be used. Vaccination should be performed only in clinically healthy animals vaccination of febrile, immunocompromised, or acutely ill animals may result in inadequate immune response and should be deferred until clinical recovery. While Rabigen Mono is highly effective when properly stored, handled, and administered, no vaccine provides 100% protection in 100% of recipients under all circumstances animals that are immunocompromised, have been exposed to rabies prior to vaccination, or have received an improperly stored dose may not achieve full protective immunity. For animals with specific health conditions including chronic illness, immunosuppressive therapy, or known vaccine sensitivities, consult your veterinarian before proceeding with vaccination. Animeal supports your pet's health and lifelong protection journey but does not replace the expertise and clinical judgement of a qualified veterinary professional.